Mateusz Sagan, MBA – Ambassador of the European Innovation Council (EIC) and startup mentor in the MIT Enterprise Forum CEE Programme, economist, manager, and strategist with over 25 years of experience in managing international companies, family businesses, and innovative biotechnology and medical startups, and a long-time member of the Lublin Medicine Cluster Board – on collaboration within the Cluster.
- The Lublin Medicine Cluster is not only a space for exchanging experiences but, more importantly, a platform for building a community based on trust and shared values. It brings together people, ideas, and essential resources, creating an environment where medical and biotechnology innovations can develop and find practical applications.
- Above all, the Cluster is an extensive network of contacts – from scientists and entrepreneurs to experts and international partners. This diversity makes it an ideal environment for forming strategic partnerships that have the potential to transform the medical and biotechnology sectors.
- Knowledge of the environment and the competencies of the entities involved in the Cluster’s activities allows for effective partner matching, significantly accelerating project development and reducing the risk of failure.
- The expert environment within the Cluster helps to develop and test ideas in response to the needs of end-users, including through joint research and development projects and clinical trials.
- Promotional activities within the Cluster enhance the visibility of the Lublin medical community both nationally and internationally.
- The Cluster is a platform for sharing experiences and a valuable source of information about funding opportunities for innovation development, ongoing projects, industry events, and emerging trends.
- The Cluster is an entire ecosystem of entities, including scientists, doctors, hospitals, institutes, and experienced managers, who together offer unique value in the creation, development, research, and implementation of biotechnology and medical innovations
_____________________________________________________________________________________________
Mateusz Sagan, MBA – Economist / Manager and Strategist in Biotechnology Projects
Mateusz Sagan holds an MBA from the University of Central Lancashire, Preston, UK.
He is a Managing Executive with over 25 years of experience in overseeing international companies, family businesses, and innovative startups. He has served as CEO of Biella Neher Holding in Poland, CEO of Iron Mountain Poland, and Managing Director at Esselte (Kyiv and Moscow). He has worked for over 10 years in Switzerland, Ukraine, and Russia. He is also an Interim Manager and a member of the Board of Directors of the Interim Managers Association in Poland.
He has led advisory projects in Eastern Europe under initiatives funded by the Ministry of Foreign Affairs and the UN (as part of UNDP projects). He is a member of the Lublin Medicine Cluster Board, a Mentor for Startups in the MIT Enterprise Forum CEE Programme, and a TEDx Conference Speaker.
For nearly a decade, he has supported Polish biotechnology and medical innovations in areas such as capital raising, innovation commercialization, and strategic management, including facilitating stock market listings (e.g. SDS Optic S.A., Vaxican Sp. z o.o., Medical Inventi S.A., FiBioMed Sp. z o.o., Biotarget Sp. z o.o., Billennium Healthcare Sp. z o.o., Tiimo Copenhagen).
He is an Ambassador of the European Innovation Council (EIC), Co-Manager of Poland’s largest Horizon2020 funding project (€4m), and Co-Creator of a €10m Venture Debt Investment project with the European Investment Bank (SDS Optic S.A.).
Currently, he serves as the Chairman of the Supervisory Board of Vaxican Sp. z o.o. and as the Vice-Chairman of the Supervisory Board of MediSensonic S.A., as well as being a Board Member of MoD Partners Sp. z o.o., Partner Limes Sp. z o.o., and FiBioMed Sp. z o.o. Additionally, he holds the position of Proxy at SDS Optic S.A.
